Campus,Year,Session,Subject,Course,Detail,Section,Title,Professor,Reported,Avg,Median,Percentile (25),Percentile (75),High,Low,<50,50-54,55-59,60-63,64-67,68-71,72-75,76-79,80-84,85-89,90-100
UBCV,2021,W,PHAR,180,,001,Pharmaceutical Topics and Communication Seminar I,Brian Rodrigues,63,89.5,89.0,86.0,93.0,95.0,80.0,,,,,,,,,,30,30
UBCV,2021,W,PHAR,202,,001,Biochemical Pharmacology,Abby Collier,38,78.9,80.0,74.3,85.3,91.0,61.0,,,,,,,,7,10,6,
UBCV,2021,W,PHAR,203,,001,Drug Delivery Technologies and Personalized Medicine Theory and Laboratory,Urs Hafeli;Shyh-Dar Li;Colin Ross;Alexander Smith,33,81.5,82.0,77.0,87.0,90.0,65.0,,,,,,,,,9,11,
UBCV,2021,W,PHAR,204,,001,Pharmaceutical Research,Abby Collier;Thomas Velenosi,33,79.2,80.0,76.0,84.0,89.0,58.0,,,,,,,6,8,10,7,
UBCV,2021,W,PHAR,205,,001,Clinical Epidemiology & Pharmaceutical Outcomes I,Mary De Vera;Mark Harrison,31,90.3,91.0,88.0,93.0,98.0,77.0,,,,,,,,,,8,20
UBCV,2021,W,PHAR,280,,001,Pharmaceutical Topics and Communication Seminar II,Jessica Kalra,35,91.4,93.0,90.0,97.0,99.0,65.0,,,,,,,,,,,27
UBCV,2021,W,PHAR,515,,001,Nanomedicines,Shyh-Dar Li,7,88.7,88.0,86.5,92.0,93.0,83.0,,,,,,,,,,,
UBCV,2021,W,PHAR,590,,002,Research in the Pharmaceutical Sciences: Principles and Methods,Abby Collier;Urs Hafeli,12,86.0,86.0,84.8,88.0,91.0,80.0,,,,,,,,,,7,
UBCV,2021,W,PHAR,591,,001,Scholarly Integrity and Research Ethics,Annalijn Conklin,15,93.7,94.0,91.5,97.5,99.0,82.0,,,,,,,,,,,13
